24 results on '"Holmøy, Trygve"'
Search Results
2. B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate
3. Body mass index influence interferon-beta treatment response in multiple sclerosis
4. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
5. Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis
6. Hereditary motor neuron disease in a large Norwegian family with a “H46R” substitution in the superoxide dismutase 1 gene
7. Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis
8. Vitamin D in the healthy and inflamed central nervous system: access and function
9. Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
10. The immunological basis for treatment of stiff person syndrome
11. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis
12. Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis
13. Severe multiple sclerosis reactivation after gonadotropin treatment
14. Iron and copper in progressive demyelination – New lessons from Skogholt's disease.
15. Skogholt's disease—A tauopathy precipitated by iron and copper?
16. The idiotype connection: linking infection and multiple sclerosis
17. Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord
18. Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis.
19. Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.
20. Towards individualised multiple sclerosis treatment
21. Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis.
22. Infectious causes of multiple sclerosis
23. Expression and functional activity of chemokine receptors in glatiramer acetate–specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate
24. Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.